PTC vs TERN · P/E 48, rev $2.74B vs $6.12B cap
PTC Inc (PTC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PTC Inc (PTC) is a software - application company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PTC currently screens at market cap $21.11B and trailing P/E 48.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PTC and TERN stock pages for the full models.
Not investment advice.